Orthofix Medical Inc. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Orthofix Medical Inc. (OFIX)
CIK: 0000884624
Period of Report: 2021-06-21

Reporting Person: BURZIK CATHERINE M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-21	Common Stock	A	5976	$0.00	Acquired	5976	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-21	Stock Option (right to buy)	$40.58	A	21361	Acquired	2031-06-21	Common Stock (21361)	Direct

Footnotes

F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021.

F2: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 21, 2021.